Variant report
Variant | esv3353021 |
---|---|
Chromosome Location | chr6:1421403-1423501 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-GMDS-13 | chr6:1423401-1425665 | NONHSAT106482 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs575978211 | chr6:1421410-1421411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs188984774 | chr6:1421421-1421422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs10214804 | chr6:1421457-1421458 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs111444832 | chr6:1421469-1421470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs571734868 | chr6:1421480-1421481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs149735083 | chr6:1421530-1421531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs564360604 | chr6:1421558-1421559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577679922 | chr6:1421615-1421616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537562186 | chr6:1421627-1421628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs79324598 | chr6:1421656-1421657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs145666177 | chr6:1421679-1421680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529285622 | chr6:1421687-1421688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549149391 | chr6:1421734-1421735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs192371537 | chr6:1421743-1421744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs377305172 | chr6:1421785-1421786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs527587694 | chr6:1421846-1421847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs184778565 | chr6:1421953-1421954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs189435758 | chr6:1421959-1421960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs114362221 | chr6:1422037-1422038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs77035062 | chr6:1422053-1422054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs549828439 | chr6:1422088-1422089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569687917 | chr6:1422108-1422109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs535386685 | chr6:1422141-1422142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs1711962 | chr6:1422164-1422165 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs199959317 | chr6:1422243-1422244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1737776 | chr6:1422244-1422245 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs535000510 | chr6:1422246-1422247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs558062752 | chr6:1422329-1422330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577792929 | chr6:1422355-1422356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs35327606 | chr6:1422372-1422373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs67321907 | chr6:1422375-1422376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs543650181 | chr6:1422489-1422490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571178847 | chr6:1422549-1422550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572316329 | chr6:1422581-1422582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs10214831 | chr6:1422595-1422596 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs557555300 | chr6:1422720-1422721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs542966958 | chr6:1422725-1422726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs180811523 | chr6:1422729-1422730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543099209 | chr6:1422730-1422731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs71971572 | chr6:1422733-1422734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563439363 | chr6:1422741-1422742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs114986748 | chr6:1422761-1422762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs377685643 | chr6:1422768-1422769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs144003879 | chr6:1422909-1422910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs186254880 | chr6:1422948-1422949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs35586988 | chr6:1422989-1422990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs111645562 | chr6:1423059-1423060 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
48 | rs569694654 | chr6:1423064-1423065 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
49 | rs528996955 | chr6:1423080-1423081 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
50 | rs375744960 | chr6:1423118-1423119 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Prader-willi syndrome | 20588305 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Developmental delay | 19490664 | CNVD |
Cancer | 21183584 | CNVD |
Multiple Epiphyseal Dysplasia | 20877625 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Glaucoma | 18694899 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung cancer | 18438408 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 20164919 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Autism | 22495311 | CNVD |
Autism | 21448237 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:1418000-1423200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr6:1419200-1423800 | Weak transcription | NHLF | lung |
3 | chr6:1419400-1424400 | Weak transcription | Fetal Stomach | stomach |
4 | chr6:1419600-1423800 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
5 | chr6:1419600-1424400 | Weak transcription | Fetal Lung | lung |
6 | chr6:1423000-1423200 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
7 | chr6:1423200-1424000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |